We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLOG
8726
PUT
DELISTED
GASLOG LTD
GLOG
$339K ﹤0.01%
91,100
+17,500
+24% +$52.9K
BSJQ icon
8727
Invesco BulletShares 2026 High Yield Corporate Bond ETF
BSJQ
$890M
$338K ﹤0.01%
13,182
-3,918
-23% -$98.4K
CADE
8728
PUT
DELISTED
Cadence Bank
CADE
$338K ﹤0.01%
+12,300
New +$311K
HYD icon
8729
PUT
VanEck High Yield Muni ETF
HYD
$4.45B
$338K ﹤0.01%
5,500
-16,500
-75% -$996K
MANT
8730
CALL
DELISTED
Mantech International Corp
MANT
$338K ﹤0.01%
+3,800
New +$287K
SOGO
8731
CALL
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$338K ﹤0.01%
41,500
-38,000
-48% -$330K
MACK
8732
CALL
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$338K ﹤0.01%
49,000
+30,900
+171% +$152K
ADPT icon
8733
Adaptive Biotechnologies
ADPT
$3.97B
$337K ﹤0.01%
5,692
-8,161
-59% -$421K
OTTR icon
8734
CALL
Otter Tail
OTTR
$3.94B
$337K ﹤0.01%
7,900
-200
-2% -$8.15K
PBTP icon
8735
Invesco 0-5 Yr US TIPS ETF
PBTP
$116M
$337K ﹤0.01%
13,012
+4,806
+59% +$124K
PTC icon
8736
PTC
PTC
$16B
$337K ﹤0.01%
2,818
-9,129
-76% -$908K
NXGN
8737
PUT
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$337K ﹤0.01%
18,500
-300
-2% -$4.76K
CRIS icon
8738
Curis
CRIS
$7.83M
$336K ﹤0.01%
+103
New +$124K
NRIM icon
8739
Northrim BanCorp
NRIM
$587M
$336K ﹤0.01%
39,640
-16,184
-29% -$128K
OMCL icon
8740
PUT
Omnicell
OMCL
$1.68B
$336K ﹤0.01%
2,800
-21,400
-88% -$2.1M
ALLT icon
8741
PUT
Allot
ALLT
$383M
$335K ﹤0.01%
31,800
+5,400
+20% +$54.8K
INVA icon
8742
PUT
Innoviva
INVA
$1.48B
$335K ﹤0.01%
+27,000
New +$291K
WTBA icon
8743
West Bancorporation
WTBA
$485M
$335K ﹤0.01%
+17,363
New +$323K
LAB icon
8744
PUT
Standard BioTools
LAB
$314M
$334K ﹤0.01%
55,600
-148,800
-73% -$978K
NAVI icon
8745
PUT
Navient
NAVI
$853M
$334K ﹤0.01%
34,000
+1,700
+5% +$16.1K
RZG icon
8746
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$141M
$334K ﹤0.01%
7,257
-69,141
-91% -$2.84M
RVNC
8747
DELISTED
Revance Therapeutics, Inc.
RVNC
$334K ﹤0.01%
11,783
-246,899
-95% -$6.4M
BTEK
8748
DELISTED
BlackRock Future Tech ETF
BTEK
$334K ﹤0.01%
+9,642
New +$287K
GSKY
8749
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$334K ﹤0.01%
72,075
+56,160
+353% +$254K
CARS icon
8750
Cars.com
CARS
$660M
$333K ﹤0.01%
29,486
-101,403
-77% -$1.02M

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.